Chiesi is an international, research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly toward both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the U.S., and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi has been the world’s largest biopharmaceutical group to be certified as a B Corp, meaning that its sustainability efforts are measured and assessed by the most rigorous global standards. The company aims to become net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma, Italy, operates in 30 countries, and employs more than 6,000 people. The Group’s research and development center in Parma works alongside six other major R&D hubs in France, the U.S., Canada, China, the U.K., and Sweden.

Website: Chiesi Farmaceutici S.p.A

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists, and the nutrition community in an interactive way. In addition to being a major publisher of nutritional papers and journals, NNI organizes and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals, including doctors, nurses, midwives, and dietitians.#

By sharing neutral, science-based information and education with healthcare professionals, the Institute fosters “Science for Better Nutrition” to help enhance the quality of life for people around the world.

Website: Nestlé Nutrition Institute

Sanofi is an innovative global healthcare company driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across approximately 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people worldwide, while putting sustainability and social responsibility at the center of our goals.

Website: Understanding RSV: Risks and Protection for Infants | Sanofi

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured.
Where treatments are smarter and less invasive.
And solutions are personal.

Inspired by patients, we take health personally—because health is personal.

We innovate with purpose to lead where medicine is going.

Website: Johnson & Johnson Innovative Medicine EMEA

Prolacta Bioscience® Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk–based nutritional products that are transforming the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide range of diseases, including applications for infants undergoing surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for screening and testing donor milk. Prolacta is a global company headquartered in Duarte, California.

Website: Prolacta Europe - Prolacta Bioscience

GE HealthCare is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions, dedicated to providing integrated solutions, services, and data analytics to make clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing connected and compassionate care while simplifying the patient journey across the care pathway. Together, we’re creating a world where healthcare has no limits.

Website: GE HealthCare Medical Systems and Solutions | GE HealthCare (United States)

As professional congress organizers, MCA Events has been helping scientific organizations and societies plan the perfect congress or event since 1999. With their multi-faceted approach, MCA consults, guides, and supports clients throughout the entire process. MCA is a full-service event planning agency that manages every aspect in a time-efficient manner, ensuring all congresses and events are strategically planned, effectively organized, and aligned with the client’s goals. The agency is accustomed to working wherever clients choose to hold their events: Europe, North and South America, and recently, Asia. MCA experts leverage their in-depth knowledge and strong industry relationships to ensure every event is a success.

The incredible progress in the care and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has long been committed to researching and developing products to meet specific nutritional needs. To this end, it established the world’s largest research center in the field, along with an international collaboration network of doctors and scientists. The resulting solutions can be tailored to meet precise nutritional requirements, such as the special stage concept designed to address the evolving needs of a developing preterm infant. Nestlé Nutrition has also developed a hydrolyzed protein that provides proven allergy prevention.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant doctors had already given up on. Little Charles Wanner went on to live more than sixty years.

The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists, and the nutrition community and stakeholders in an interactive way. In addition to being a major publisher of nutritional papers and journals, NNI organizes and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals, including doctors, nurses, midwives, and dietitians.

By sharing neutral, science-based information and education for healthcare professionals, the Institute promotes Science for Better Nutrition to help improve quality of life around the world.

Website: Nestlé Nutrition Institute

Prolacta Bioscience® Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk–based nutritional products, transforming the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a broad range of diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta sets the industry standard with the highest quality and safety protocols for screening and testing donor milk. Prolacta is a global company headquartered in Duarte, California.

Website: Prolacta Europe - Prolacta Bioscience

SIMCharacters develops pediatric simulators to improve medical care for critically ill children. Founder Jens Schwindt, a neonatologist, has learned that a highly professional interdisciplinary team is essential for effective medical care. SIMCharacters’ High Emotion Preterm Simulator, Paul, enables medical teams to train for critical neonatal emergencies in highly realistic conditions.

Website: SIMCharacters - High Emotion Simulation

Chiesi is an international, research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly toward both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the U.S., and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi has been the world’s largest biopharmaceutical group certified as a B Corp, meaning its sustainability efforts are measured and assessed by the most ambitious global standards. The company aims to become net-zero by 2035. With over 85 years of experience, Chiesi is headquartered in Parma, Italy, operates in 30 countries, and employs more than 6,000 people. The Group’s research and development center in Parma works alongside six other major R&D hubs in France, the U.S., Canada, China, the U.K., and Sweden.

Website: Chiesi Farmaceutici S.p.A